Steering Committee

Honorary Chairs

• Samuel L. Stanley, Jr., MD, President, Stony Brook University
• Samuel Aronson, PhD, Director, Brookhaven National Laboratory
• Bruce Stillman, PhD, President & CEO, Cold Spring Harbor Laboratory

Advisors (Industry)

• Richard A. Basile, Founder, COO & General Partner, BioPointis Alliance, LLC
• Karen Bernstein, PhD, Chairman, Editor-in-Chief, BioCentury Publications Inc
  
• Ron Cohen, MD, President & CEO, Acorda Therapeutics, Inc.
• Ellen B. Corenswet, Partner, Covington & Burling LLP
• Pamela Demain, MBA, Executive Director, Corporate Licensing, Merck & Co., Inc.
• Sara Jane Demy, President, Demy-Colton Life Science Advisors
• Andy Dorner, PhD, Vice President, Millennium Pharmaceuticals
• Sudha Kadiyala, PhD, Senior Director, Business Development & Strategic Planning, Advanced Technologies & Regenerative Medicine, LLC
  
• Ginny Llobell, Vice President, Defined Health
• Joel S. Marcus, Chairman, Chief Executive Officer & Founder, Alexandria Real Estate Equities, Inc/ Alexandria Venture Investments
• Sharon Mates, PhD, Chairman and CEO, Intra-Cellular Therapies, Inc.
  
• Ronald Newbold, PhD, Vice President, Strategic Research Partnerships, Pfizer Inc
• Charles Ryan, PhD, JD, VP & Chief Intellectual Property Counsel, Forest Laboratories, Inc.
• Mary C. Tanner, Managing Director, Peter J. Soloman and Company
• Christopher Yochim, Director, External Relations & Corporate Business Development, AstraZeneca

Advisors (Academia/Non-Profit)

• Stephen Mon Wei Chang, PhD, Vice President, Research and Development, New York Stem Cell Foundation
• Barry Coller, MD, Vice President, Medical Affairs, Physician-in-Chief, The Rockefeller University
• Gerald Fischbach, MD, Scientific Director, Simons Foundation
• Kenneth Kaushanski, MD, MACP, Senior Vice President, Health Sciences Dean, School of Medicine, Stony Brook University
• Susan Riley Keyes, PhD, JD, Vice President for Region Meetings, AUTM
  
• Yung S. Lie, PhD, Scientific Director, Damon Runyon Cancer Research Foundation
• Viviane Martin, PhD, Associate Director, Memorial Sloan-Kettering Cancer Center
  
• Karen E. Nelson, PhD, Professor, Director, Rockville Maryland Campus, J. Craig Venter Institute
• Glenn D. Prestwich, PhD, Presidential Professor, Medicinal Chemistry, University of Utah
• Brock C. Reeve, MPhil, MBA, Executive Director, Harvard Stem Cell Institute
• Clinton T. Rubin, PhD, Distinguished Professor, Chair, Department of Biomedical Engineering, Stony Brook University, Director, Center for Biotechnology
• Donna See, MPH, MBA, Director, Strategic Initiatives, Columbia Technology Ventures
• Barbara S. Slusher, PhD, MBA, Chief Scientific Officer, Brain Science Institute, Johns Hopkins School of Medicine
• Jon Soderstrom, PhD, Managing Director, Office of Cooperative Research, Yale University
• A. Donny Strosberg, PhD, Professor, The Scripps Research Institute-Florida
• Kevin J. Tracey, MD, Professor & President, Feinstein Institute for Medical Research